Bleakley Financial Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.66M Buy
12,572
+2,399
+24% +$847K 0.05% 304
2026
Q2
$3.65M Buy
+10,173
New +$3.11M 0.05% 316
2025
Q1
– Sell
-2,170
Closed -$711K – 1028
2024
Q4
$711K Sell
2,170
-188
-8% -$59.2K 0.02% 512
2024
Q3
$708K Buy
2,358
+76
+3% +$23.3K 0.02% 495
2024
Q2
$752K Buy
2,282
+108
+5% +$38.2K 0.02% 485
2024
Q1
$860K Buy
2,174
+41
+2% +$15.2K 0.02% 468
2023
Q4
$751K Sell
2,133
-12
-0.6% -$4.25K 0.02% 479
2023
Q3
$805K Sell
2,145
-55
-3% -$21.3K 0.03% 423
2023
Q2
$841K Buy
2,200
+38
+2% +$13.6K 0.03% 448
2023
Q1
$749K Sell
2,162
-105
-5% -$30.7K 0.03% 462
2022
Q4
$534K Buy
+2,267
New +$537K 0.02% 537

Other funds holding WST

Bleakley Financial Group's WST Position: Q3 2026 in Review

Bleakley Financial Group increased its West Pharmaceutical (WST) stake by 24% in Q3 2026, buying an estimated $847K and bringing the position to 12,572 shares worth $4.66M. The position accounts for 0.05% of the portfolio, ranked #304.

Bleakley Financial Group first reported a position in WST in Q4 2022 and has held it in 11 quarters since. 752 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Bleakley Financial Group held 12,572 shares of West Pharmaceutical worth $4.66M as of Q3 2026.
  • Bleakley Financial Group bought 2,399 West Pharmaceutical shares in Q3 2026, an estimated $847K.
  • West Pharmaceutical made up 0.05% of Bleakley Financial Group's portfolio in Q3 2026, its #304 holding.
  • Bleakley Financial Group first reported a position in West Pharmaceutical in Q4 2022 and has held it in 11 quarters since.
  • 752 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Bleakley Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.